The Decline in Corporate Research: Should We Worry? | The Evidence
The Center for Innovation Policy's conference, "The Decline in Corporate Research: Should We Worry?", was held on March 31, 2017, at Duke's "Duke in D.C." offices.
Panel 1: The Evidence
Moderator: Eduardo Porter, The New York Times
Presentation: Ashish Arora and Sharon Belenzon, Duke Fuqua School of Business
The Decline in Corporate Research: Should We Worry?
Government data and research point to a long decline in US corporate investment in upstream research. How pervasive is this trend across industries, technologies, and firms of different sizes? How does it compare with research spending by the federal government, universities, and companies abroad? Does it reflect less reliance on research, whoever performs it? Is it explained by capital market pressures, global competition, or other factors? Has it contributed to the slowdown in productivity growth? Are there other reasons policymakers should be concerned? If so, what policy levers should they look to—e.g., intellectual property, tax, government R&D spending, or antitrust enforcement?
This program was sponsored by a grant from the Ewing Marion Kauffman Foundation.
Видео The Decline in Corporate Research: Should We Worry? | The Evidence канала Duke University School of Law
Panel 1: The Evidence
Moderator: Eduardo Porter, The New York Times
Presentation: Ashish Arora and Sharon Belenzon, Duke Fuqua School of Business
The Decline in Corporate Research: Should We Worry?
Government data and research point to a long decline in US corporate investment in upstream research. How pervasive is this trend across industries, technologies, and firms of different sizes? How does it compare with research spending by the federal government, universities, and companies abroad? Does it reflect less reliance on research, whoever performs it? Is it explained by capital market pressures, global competition, or other factors? Has it contributed to the slowdown in productivity growth? Are there other reasons policymakers should be concerned? If so, what policy levers should they look to—e.g., intellectual property, tax, government R&D spending, or antitrust enforcement?
This program was sponsored by a grant from the Ewing Marion Kauffman Foundation.
Видео The Decline in Corporate Research: Should We Worry? | The Evidence канала Duke University School of Law
Показать
Комментарии отсутствуют
Информация о видео
6 апреля 2017 г. 2:38:16
00:40:09
Другие видео канала
Sea Turtles and the Duke Law Environmental Law & Policy ClinicAruna Kashyap & Achal Prabhala | Human Rights and the COVID Vaccine: Distribution and AccessDuke Law Graduation 2017 | Michelle Mansour LLM '17Gail Feagles '76 shares thoughts on Richard Nixon, a fellow Duke Law graduateKatharina Riedl LLM '13 speaks about the strong career planning support at Duke LawEyewitness Summit 2020: New Directions in Eyewitness Evidence Research & Practice | Thomas AlbrightCarl J. Stewart, Jr. '61 talks about his Duke Law experienceBolch Prize for the Rule of Law: A Ceremony Honoring the International Association of Women JudgesTobias Wetlitzky LLM '20 discusses Duke’s cutting-edge courses and extra-curricular experiencesAlexander Sorton LLM '17 discusses the strength of classroom experiences and the Durham communityThe Duke-Geneva Institute in Transnational LawThe Decline in Corporate Research: Should We Worry? | 3rd SessionJohn Knox | The Human Right to a Healthy EnvironmentData Governance Design Conference | Opening Keynote, Question & AnswersDuke Law LLM Class of 2021 Convocation | Justin Miller Award Winner Miroslav Petkov GeorgievDELPF Symposium 2018: From Here to There | Panel 1, BuildingBolch Institute | Coping with COVID: How Courts are Preserving Access to JusticeGeorge Wilkerson & Tessie Castillo | Their Own Words: The Impact of the Death Penalty in AmericaCivil Rights, Duke, and Durham in the 1960s2015 Hardt Cup Finals